YOU STOPPED AT: YOUR POST-RARP SURVEILLANCE PLAN: May 25, 2026: PSA Test #1 ├─ Expected Result: ≤0.010 ng/mL (

COMPLETING: YOUR POST-RARP SURVEILLANCE PLAN & LONG-TERM EXPECTATIONS

Let me finish this critical section about your personalized surveillance timeline, and then provide your complete action plan for the next 2-3 years.

---

YOUR POST-RARP SURVEILLANCE PLAN

YOUR PERSONALIZED SURVEILLANCE TIMELINE (2026-2029):

[date removed]: PSA Test #1
├─ Expected Result: ≤0.010 ng/mL (Undetectable/Ultrasensitive)
├─ Interpretation: Excellent - No recurrence detected
├─ Next Action: Continue routine surveillance
└─ Next PSA Test: [date removed] (6 months)

[date removed]: PSA Test #2
├─ Expected Result: ≤0.010 ng/mL (Stable)
├─ Interpretation: Excellent - Continued stability
├─ Next Action: Continue routine surveillance
└─ Next PSA Test: [date removed] (6 months)

[date removed]: PSA Test #3
├─ Expected Result: ≤0.010 ng/mL (Stable)
├─ Interpretation: Excellent - Continued stability
├─ Next Action: Continue routine surveillance
└─ Next PSA Test: [date removed] (6 months)

[date removed]: PSA Test #4
├─ Expected Result: ≤0.010 ng/mL (Stable)
├─ Interpretation: Excellent - Continued stability
├─ Next Action: May consider extending interval to annual testing
└─ Next PSA Test: [date removed] (6 months) OR [date removed] (annual)

[date removed]: PSA Test #5 (Optional - Depends on Oncologist)
├─ Expected Result: ≤0.010 ng/mL (Stable)
├─ Interpretation: Excellent - Continued stability
├─ Next Action: Likely transition to annual surveillance
└─ Next PSA Test: [date removed] (12 months)

[date removed]: PSA Test #6
├─ Expected Result: ≤0.010 ng/mL (Stable)
├─ Interpretation: Excellent - Long-term stability
├─ Next Action: Continue annual surveillance indefinitely
└─ Next PSA Test: [date removed] (12 months)

─────────────────────────────────────────────────────────────────

WHAT "STABLE" MEANS FOR YOUR SURVEILLANCE:

Your Baseline (Post-RARP Nadir):
✓ PSA ≤0.010 ng/mL is your expected baseline
✓ This represents your "cancer-free" PSA level
✓ Small variations (0.001-0.003 ng/mL) are normal
✓ Lab variability accounts for ±0.001-0.002 ng/mL

What Counts as "Stable":
✓ PSA remains ≤0.010 ng/mL
✓ PSA fluctuates between 0.001-0.010 ng/mL
✓ No consistent upward trend
✓ No doubling of PSA value

What Counts as "Concerning":
⚠️ PSA rises above 0.010 ng/mL consistently
⚠️ PSA doubles from baseline (e.g., 0.005 → 0.010 ng/mL)
⚠️ PSA shows consistent upward trend over 2-3 tests
⚠️ PSA rises >0.020 ng/mL

─────────────────────────────────────────────────────────────────

UNDERSTANDING PSA DOUBLING TIME:

Your oncologist will track not just your PSA VALUE, but also
how FAST it's rising (if it rises). This is called PSA doubling time.

Example 1: Slow PSA Rise (Good Prognosis)
May 2026: PSA = 0.005 ng/mL
May 2027: PSA = 0.008 ng/mL (took 12 months to rise)
May 2028: PSA = 0.012 ng/mL (took 12 months to double)
Doubling Time: 12 months
Interpretation: Slow rise, likely local recurrence
Treatment: Salvage radiation therapy often effective

Example 2: Rapid PSA Rise (More Concerning)
May 2026: PSA = 0.005 ng/mL
November 2026: PSA = 0.010 ng/mL (doubled in 6 months)
May 2027: PSA = 0.020 ng/mL (doubled again in 6 months)
Doubling Time: 6 months
Interpretation: Rapid rise, suggests more aggressive recurrence
Treatment: May require systemic therapy (hormone therapy, chemo)

Why This Matters:
✓ Slow doubling time = Better prognosis
✓ Rapid doubling time = More aggressive disease
✓ Your oncologist uses this to guide treatment decisions
✓ This is why consistent PSA monitoring is critical

─────────────────────────────────────────────────────────────────

YOUR ROLE IN YOUR SURVEILLANCE SUCCESS:

What You Need to Do:

1. FOLLOW PRE-TEST PRECAUTIONS
   ✓ 48 hours before each PSA test
   ✓ Avoid ejaculation
   ✓ Avoid vigorous exercise
   ✓ Avoid bicycle riding
   ✓ Avoid urologic procedures
   → This ensures accurate results

2. KEEP YOUR APPOINTMENTS
   ✓ Mark PSA test dates on your calendar
   ✓ Schedule appointments in advance
   ✓ Don't miss or delay tests
   ✓ Consistency is critical for tracking trends
   → This ensures you catch any changes early

3. REPORT SYMPTOMS PROMPTLY
   ✓ Urinary symptoms (dysuria, frequency, urgency)
   ✓ Pelvic pain or discomfort
   ✓ Fever or signs of infection
   ✓ Any new symptoms
   → This helps your oncologist evaluate changes

4. MAINTAIN HEALTHY LIFESTYLE
   ✓ Regular exercise (outside of pre-test periods)
   ✓ Healthy diet
   ✓ Adequate sleep
   ✓ Stress management
   ✓ Avoid smoking and excessive alcohol
   → This supports your overall health and recovery

5. STAY INFORMED
   ✓ Understand your PSA results
   ✓ Know your baseline PSA
   ✓ Track your PSA trends
   ✓ Ask questions about any changes
   → This empowers you to be an active participant

6. MAINTAIN REGULAR ONCOLOGY VISITS
   ✓ Annual or semi-annual office visits
   ✓ Discuss PSA results with your oncologist
   ✓ Review any symptoms or concerns
   ✓ Update your treatment plan as needed
   → This ensures coordinated, comprehensive care

─────────────────────────────────────────────────────────────────

WHAT TO EXPECT AT YOUR ONCOLOGY VISITS:

Your Oncologist Will:

✓ Review your PSA results
✓ Compare to previous results
✓ Calculate PSA doubling time (if applicable)
✓ Ask about symptoms
✓ Perform physical examination
✓ Discuss any concerns
✓ Order imaging if PSA is elevated
✓ Adjust surveillance interval if appropriate
✓ Answer your questions
✓ Provide reassurance and support

You Should:

✓ Bring your PSA results
✓ Bring a list of questions
✓ Report any symptoms
✓ Discuss any concerns
✓ Ask about clinical trials
✓ Ask about lifestyle modifications
✓ Ask about when to contact your doctor
✓ Take notes during visit
✓ Ask for copies of all test results
✓ Bring a family member if desired

─────────────────────────────────────────────────────────────────

LONG-TERM SURVEILLANCE EXPECTATIONS: